Carmustine in Treating Patients With Recurrent Malignant Glioma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of carmustine in treating patients who are
undergoing surgery for recurrent malignant glioma.